STAT+: J&J spends $1 billion to enter KRAS race for cancer treatments

STAT News

Johnson & Johnson said it will purchase the startup Firefly Bio for $1 billion in an effort to expand its work in the suddenly buzzy field of KRAS inhibitors. ...

전문 보기

이 뉴스, 독자들은 어떻게 느꼈나요?

첫 반응을 남겨보세요

로그인하면 감정 반응에 참여할 수 있어요.

STAT+: J&J spends $1 billion to enter KRAS race for cancer treatments

이 뉴스, 독자들은 어떻게 느꼈나요?

관련 뉴스

'science' 카테고리 뉴스

Probiotics could help treat depression

Rural–urban differences may exist in use of mental health care for veterans with serious mental illness

Could daytime light exposure help protect against dementia?

STAT의 다른 기사

STAT+: How a biotech turned a trial failure into an AI model

The U.S. infant mortality rate fell to an all-time low, though it still trails other similar nations

STAT+: ARCH-launched Neumora stops depression program